5 Key Takeaways

• 1

  Optical genome mapping (OGM) shows promise as a first-line test in diagnosing adult acute leukemia, outperforming traditional methods.

• 2

  In analytical validation, OGM achieved 100% specificity, 96% sensitivity, and 98% accuracy across 83 samples.

• 3

  OGM identified 640 reportable variants in 200 adult acute leukemia cases, surpassing the 444 detected by karyotype and FISH.

• 4

  The integration of OGM into workflows led to changes in diagnostic classification or risk stratification in 35 cases.

• 5

  Although OGM has longer turnaround times than karyotyping, it enhances detection of clinically relevant alterations in acute leukemia.